AI-powered search

Isotretinoin Pearls

Featuring Linda Stein Gold, MD | Co-Director |

Director Clinical Research 
Henry Ford Health System 
Detroit, MI

| Published June 01, 2024

Isotretinoin is an oral systemic retinoid indicated for severe acne or moderate acne not responsive to conventional therapy. In this session, Linda F. Stein Gold, MD discusses the recommendations for laboratory monitoring for patients taking isotretinoin and the data on which laboratory abnormalities may occur with isotretinoin. Further, she highlights the risk factors for relapse, particularly insufficient dosing. Dr. Stein Gold also discusses the benefit of taking isotretinoin with fatty food and presents data regarding the improved delivery of the drug. Additionally, Dr. Stein Gold examines the data regarding the risk of depression and inflammatory bowel disease for isotretinoin and provides pearls for clinicians for monitoring.


Related Media

Powered by Polaris TM

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us


Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved